Vistagen Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of VTGN for the last quarter is 183.00 k USD, and it's 117.86% higher compared to the previous quarter. The net income of Q2 24 is -12.96 M USD.